Vol 52, No 6 (2021)
Clinical vignette
Published online: 2021-11-08
Diagnostic and treatment dilemmas in case of the severe course of multicentric Castleman disease
1, 2
, 3, 2, 2, 3, 2, 4
, 3, 2, 2, 3, 2, 4
Acta Haematol Pol 2021;52(6):601-603.
Abstract
Not available
Keywords: multicentric Castleman diseaseTAFRO
References
- Castleman B, Iverson L, Menendez V. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer. 1956; 9(4): 822–830, doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4.
- Gaba AR, Stein RS, Sweet DL, et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978; 69(1): 86–90.
- Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998; 128(8): 657–662.
- Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol Clin North Am. 2018; 32(1): 11–21.
- Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014; 123(19): 2924–2933.
- Kojima M, Motoori T, Asano S, et al. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract. 2007; 203(6): 423–431.
- Kojima M, Motoori T, Nakamura S. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother. 2006; 60(10): 663–672.
- Fajgenbaum DC, Uldrick T, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood. 2017; 129(12): 1646–1657.
- Kawabata H, Takai K, Kojima M, et al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013; 53(1): 57–61.
- Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: where are we now? . Semin Diagn Pathol. 2016; 33(5): 294–306.